ArticleCureus2026
Clinicopathological Characteristics and Postoperative Outcomes of Patients Undergoing Modified Radical Mastectomy: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Breast cancer remains the most common malignancy among women worldwide and a leading cause of cancer-related mortality, particularly in developing countries where delayed presentation and limited screening facilities persist. Objective The objective of this study is to evaluate the clinicopathological profile and short-term (30-day) postoperative outcomes of patients with breast cancer undergoing modified radical mastectomy (MRM) in a resource-limited tertiary care setting while exploring factors that may influence surgical complications. Methods This retrospective observational study included 210 female patients who underwent MRM between January 2022 and December 2024. Demographic, clinical, histopathological, perioperative, and 30-day postoperative outcome data were extracted from hospital records and analyzed using SPSS version 26.0 (IBM Corp., Armonk, NY). Results The mean age was 51.4 ± 10.2 years, with 63.8% of patients being postmenopausal. Invasive ductal carcinoma was the predominant histological subtype (89.5%). Most patients presented with locally advanced disease (stage IIIC, 60%), and axillary lymph node involvement was observed in 65.7%. Estrogen receptor (ER) positivity was noted in 62.9%, progesterone receptor (PR) positivity in 57.1%, human epidermal growth factor receptor 2 (HER2/neu) overexpression in 25.7%, and triple-negative breast cancer in 17.1% of cases. The mean operative time was 115 ± 25 minutes, and the mean blood loss was 210 ± 60 mL. Postoperative complications occurred in 27.6% of patients, most commonly seroma formation (16.2%). No 30-day postoperative mortality was observed. Conclusion Modified radical mastectomy remains a safe and effective surgical option for breast cancer management in resource-limited settings, providing acceptable morbidity and reliable short-term outcomes, particularly among patients presenting with advanced disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.